Hermes lands FDA clearance for Affinity
Swedish nuclear medicine software developer Hermes Medical Solutions has received...Read more on AuntMinnie.comRelated Reading: Hermes gets FDA clearance for radiation dose software Hermes launches new radiation therapy software Hermes appoints new president, CEO Hermes launches new liver analysis software Hermes expands North America executive team (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 19, 2020 Category: Radiology Source Type: news

New therapy option identified for early-stage breast cancer
(Society of Nuclear Medicine and Molecular Imaging) Radionuclide therapy has been successful in delaying the growth of disseminated tumor cells in early-stage breast cancer. Radium-233 dichloride not only impacts cells directly hit by radiation but also has significant effects on cells outside of the radiation field, according to research published in The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

PET/MRI identifies notable breast cancer imaging biomarkers
(Society of Nuclear Medicine and Molecular Imaging) Researchers have identified several potentially useful breast cancer biomarkers that indicate the presence and risk of malignancy, according to new research published in The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2020 Category: Cancer & Oncology Source Type: news

Medical News Today: How proton radiotherapy can kill cancer in milliseconds
In mice, researchers have devised a technology that can deliver proton radiation, killing cancer cells while preserving healthy tissue, in under 1 second. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 14, 2020 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

DOE waives export ban on highly enriched uranium
The U.S. Department of Energy (DOE) is moving to allow the export of weapons-grade...Read more on AuntMinnie.comRelated Reading: DOE funds for Mo-99 production progress DOE to fund U.S. Mo-99 production Molybdenum-99 shortage may soon ease SNMMI letter urges FDA to ease shortage of gallium-68 Can nuclear medicine avoid another Mo-99 shortage? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 9, 2020 Category: Radiology Source Type: news

Radiomedix, Curium file NDA for PET agent
Biotechnology firm RadioMedix and global nuclear medicine firm Curium have...Read more on AuntMinnie.comRelated Reading: RadioMedix lands $2M grant from NCI FDA to fast track RadioMedix, Curium PET agent RadioMedix, Curium ink deal on new PET agent RadioMedix, ITM ink radiopharmaceutical generator deal Curium to market xenon-133 gas in the U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 8, 2020 Category: Radiology Source Type: news

Using Imaging for Early Intervention After a Heart Attack
Researchers from Klinikum rechts der Isar der Technical University of Munich, Germany have found that a new radiotracer can effectively image fibroblast activation after a heart attack and identify a window of time during which cardiac fibrosis can be prevented and the disease course altered. The team used a novel 68Ga-labeled fibroblast activation protein (FAP) inhibitor and research regarding the technique was published in the December issue of The Journal of Nuclear Medicine The preclinical study included 20 rats subjected to myocardial infarction by permanent ligation of the left anterior descending coronary artery, as...
Source: MDDI - January 6, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Cardiovascular Imaging Source Type: news

New radiotracer offers opportunities for earlier intervention after heart attack
(Society of Nuclear Medicine and Molecular Imaging) A new radiotracer can effectively image fibroblast activation after a heart attack, identifying a window of time during which cardiac fibrosis can be prevented and the disease course altered. The study is featured in the The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 2, 2020 Category: International Medicine & Public Health Source Type: news

IBA sells part of dosimetry unit
Proton therapy developer Ion Beam Applications (IBA) has sold its RadioMed...Read more on AuntMinnie.comRelated Reading: IBA and CAMH partner to build nuclear medicine program IBA takes next step in China deal IBA to install carbon therapy in France IBA posts revenue increase in 1st half of 2019 IBA inks deal to install cyclotron in South Korea (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 17, 2019 Category: Radiology Source Type: news

Medical News Today: What does a radiologist do?
A radiologist is a doctor who interprets medical imaging, such as X-rays. Learn more about what they do and the education that they receive here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 17, 2019 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

Finding a non-invasive way to predict effectiveness of cancer therapy
(Society of Nuclear Medicine and Molecular Imaging) Researchers have taken a critical step toward developing a non-invasive nuclear medicine technique that can predict the effectiveness of therapy for cancerous tumors, allowing for personalized, precision treatment. The study is featured in the December issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 13, 2019 Category: Cancer & Oncology Source Type: news

Massive VHA audit explores reasons for imaging delays
A massive review of outpatient radiology and nuclear medicine services in the...Read more on AuntMinnie.comRelated Reading: VA endorses AI research with new institute VA: Delay in patient diagnosis leads to suicide VA identifies radiology reporting delays at Kan. hospital Did VA hospitals cancel valid radiology orders to clear backlog? Veterans get inappropriate prostate imaging outside VA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2019 Category: Radiology Source Type: news

Novel theranostic reagent could enhance detection and therapy of prostate cancer
(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine radiotracer could help identify the extent of metastatic prostate cancer and select patients for therapy. The study is featured in The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 26, 2019 Category: Cancer & Oncology Source Type: news

Prostate cancer: radiation therapy effective in patients with no further treatment options
(Saarland University) Prostate cancer accounts for 26 percent of male cancer cases diagnosed in Germany. Scientists and doctors at Saarland University Hospital recently conducted a clinical trial in which they established the effectiveness of a therapeutic method that is very successful in controlling late-stage prostate tumours and their metastases without causing serious side effects. The pilot study has been published in the highly respected medical journal European Journal of Nuclear Medicine and Molecular Imaging. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2019 Category: Cancer & Oncology Source Type: news

Medical News Today: Brain cancer: Lithium may restore cognitive function after radiation
New research has found that lithium improves memory and learning capabilities in young female mice that have undergone radiation treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 22, 2019 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

Curium to file NDA for generic form of DaTscan
Nuclear medicine firm Curium Pharma plans to submit an abbreviated new drug...Read more on AuntMinnie.comRelated Reading: Curium changes pricing for Tc-99m product FDA to fast track RadioMedix, Curium PET agent Curium, Progenics partner on PET agent in Europe RadioMedix, Curium ink deal on new PET agent GE's DaTscan awarded Canadian approval (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 13, 2019 Category: Radiology Source Type: news

New technique could optimize PSMA-targeted prostate cancer therapy
(Society of Nuclear Medicine and Molecular Imaging) Researchers have discovered a new way to optimize results in treating patients with prostate cancer tumors while minimizing negative side effects. The study is featured in the November issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2019 Category: Cancer & Oncology Source Type: news

DOSIsoft gets FDA nod for MU2net software
Radiation oncology and nuclear medicine software developer DOSIsoft has received...Read more on AuntMinnie.comRelated Reading: Butterfly Network launches new software for portable US Elekta, DOSIsoft sign distribution agreement DOSIsoft wins FDA nod for Planet Onco Dose software Densitas launches mammo quality assessment software DOSIsoft gets FDA OK for ThinkQA-EPIbeam, updates Planet Dose (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 11, 2019 Category: Radiology Source Type: news

SNMMI agrees with CMS 2020 fee schedules
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is breathing...Read more on AuntMinnie.comRelated Reading: CMS issues final Medicare Physician Fee Schedule for 2020 CMS final rule for MPFS could cost radiology $5B ASTRO, ACR update RT practice parameters CMS gets pushback on PET fee cuts ASTRO wants changes to CMS payment proposal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 6, 2019 Category: Radiology Source Type: news

Medical News Today: What to know about angiograms
An angiogram is an X-ray of the blood vessels. Doctors use angiograms to help diagnose medical conditions related to the arteries or heart. Learn more about angiograms here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 29, 2019 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

IBA and CAMH partner to build nuclear medicine program
Proton therapy developer Ion Beam Applications (IBA) and Azrieli Centre for...Read more on AuntMinnie.comRelated Reading: IBA takes next step in China deal IBA to install carbon therapy in France IBA posts revenue increase in 1st half of 2019 IBA inks deal to install cyclotron in South Korea IBA takes order from Kan. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 11, 2019 Category: Radiology Source Type: news

Nihon Medi-Physics Launches In-house Production of Molybdenum-99
Nihon Medi-Physics (NMP), the leading radiopharmaceutical company in nuclear medicine in Japan, announced that they have launched a project to start in-house production of Molybdenum-99 (99Mo), the...(PRWeb October 11, 2019)Read the full story at https://www.prweb.com/releases/nihon_medi_physics_launches_in_house_production_of_molybdenum_99/prweb16629956.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 11, 2019 Category: Pharmaceuticals Source Type: news

Can Radiolucent Foreign Bodies Be Identified?
Discussion Foreign bodies are common problems for young children particularly ages 2-4 years who will mouth many objects and aspirate or swallow them. Children will also place foreign objects in other body orifices such as ears or noses. It is also not uncommon that young girls will inadvertently have toilet paper caught in the vaginal area during hygiene. Many of these foreign bodies may work their way out naturally not causing any problems, or may come to attention later because of chronic problems such as a foul-smell or discharge. Older children may tell adults that they have placed a foreign body in an orifice and thu...
Source: PediatricEducation.org - October 7, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

What Are Pulmonary Embolism Risk Factors?
Discussion Pulmonary embolism (PE) is potentially life-threatening but fortunately rare event especially in the pediatric population. It was first described in children in 1861. PE is likely underreported because of minimal or non-specific clinical symptoms. The incidence is estimated at 0.05-4.2% with the 4.2% based on autopsy reports. It is probably also increasing as more central venous catheters (CVC) are used, and more children are surviving previously poor prognostic diseases. There is a bimodal distribution with cases
Source: PediatricEducation.org - September 23, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

SNMMI sets submission schedule for 2020 meeting
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has adjusted...Read more on AuntMinnie.comRelated Reading: SNMMI announces leadership slate for 2019-2020 SNMMI, ACR create clinical data registry SNMMI, ACNM oppose relaxing radiopharma user rules Japanese researchers receive SNMMI fellowship SNMMI awards technologists (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2019 Category: Radiology Source Type: news

More Mo-99 production woes at ANSTO
A mechanical problem at the Australian Nuclear Science and Technology Organisation's...Read more on AuntMinnie.comRelated Reading: Report: ANSTO readies price hikes for isotopes ANSTO workers exposed to radiation ANSTO licensed to fully supply Mo-99 ANSTO nets funds for nuclear medicine project ANSTO offers virtual reality tours of OPAL reactor (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 13, 2019 Category: Radiology Source Type: news

Progenics Collaborates with Veterans Affairs on AI Research Program for Medical Image Analysis
A close collaboration between the Veterans Affairs Greater Los Angeles Healthcare System (VAGLAHS) and Progenics Pharmaceuticals will focus on the development and validation of artificial intelligence (AI) algorithms in medical images for disease management for veterans with prostate cancer. “The promise of AI in healthcare, specifically in this collaboration, is to increase the quality of care while driving down costs,” said Aseem Anand, PhD, vice president and site manager of EXINI Diagnostics, in an interview with MD+DI. EXINI Diagnostics, recently acquired by Progenics, ...
Source: MDDI - September 11, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

Digirad acquires modular housing firm
Digirad is expanding its portfolio beyond nuclear medicine equipment and services...Read more on AuntMinnie.comRelated Reading: Digirad reports continued revenue decline in Q4, 2018 Digirad stock faces Nasdaq sanction Digirad CFO to leave company Digirad posts drop in revenue for Q4, 2017 Philips closes purchase of Digirad service contracts (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2019 Category: Radiology Source Type: news

NaF-PET/CT does well in detecting prostate metastases
Nuclear medicine physicians showed high accuracy and consistency when reading...Read more on AuntMinnie.comRelated Reading: NaF-PET/CT rarely finds prostate cancer bone metastases Could Ga-68 PSMA PET become essential for prostate cancer? Delayed NaF-PET enhances coronary plaque detection Can deep learning monitor lesions on F-18 NaF PET/CT? CMS again declines coverage for NaF-PET scans (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 6, 2019 Category: Radiology Source Type: news

Curium changes pricing for Tc-99m product
Nuclear medicine firm Curium Pharma has announced plans to implement a new...Read more on AuntMinnie.comRelated Reading: FDA to fast track RadioMedix, Curium PET agent Curium, Progenics partner on PET agent in Europe RadioMedix, Curium ink deal on new PET agent Curium to market xenon-133 gas in the U.S. Curium switches Mo-99 production process to LEU (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 4, 2019 Category: Radiology Source Type: news

Former Speaker of the House Paul Ryan joins SHINE Medical board
Former Wisconsin Congressman and Speaker of the House  Paul Ryan has joined the board of directors at SHINE Medical Technologies LLC, a Janesville-based nuclear medicine company that's setting up the commercial production of a radioisotope used in medical imaging. Ryan was U.S. House Speaker when the Republican easily won re-election in 2016 for hi s ninth term in the House of Representatives, representing Wisconsin's 1st Congressional District, which includes Janesville, since 1998. He chose… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 27, 2019 Category: Pharmaceuticals Authors: Nick Williams Source Type: news

Report: ANSTO readies price hikes for isotopes
The Australian Nuclear Science and Technology Organization (ANSTO) is rolling...Read more on AuntMinnie.comRelated Reading: ANSTO workers exposed to radiation ANSTO licensed to fully supply Mo-99 ANSTO nets funds for nuclear medicine project Australian reactor to resume Mo-99 shipments this week Australian agency orders review of Mo-99 procedures (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 26, 2019 Category: Radiology Source Type: news

Gene test picks out prostate cancers that could respond to 'search-and-destroy' medicine
(Institute of Cancer Research) Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports.An emerging class of drugs are made up of a radioactive particle that kills cells attached to a 'homing device' to seek out cancers by detecting the presence of a target molecule on their surface.These new 'search-and-destroy' treatments are starting to show promise -- but not all patients respond. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2019 Category: Cancer & Oncology Source Type: news

Di Carli Wins SNMMI Georg de Hevesy Nuclear Medicine Pioneer Award
Marcelo Di Carli, MD, chief in the Division of Nuclear Medicine and Molecular Imaging in the Department of Radiology and director of the Cardiovascular Imaging Program in Radiology and the Department of Medicine, was selected for the Society of Nucle (Source: BWH News)
Source: BWH News - July 19, 2019 Category: Hospital Management Source Type: news

Groups urge passage of radiopharmaceutical bill
Nuclear medicine and molecular imaging advocates went to Capitol Hill in Washington,...Read more on AuntMinnie.comRelated Reading: Video from SNMMI 2019: Dr. Barry Siegel on PET reimbursement IMV: PET/CT drives PET scan volume to new heights IDEAS study confirms amyloid PET's value for Alzheimer's Both sides weigh in on plan to loosen radiopharma rules How Medicare fee schedule changes will affect radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 17, 2019 Category: Radiology Source Type: news

Female radiologists read fewer advanced imaging studies
Female radiologists interpret fewer advanced imaging studies than their male...Read more on AuntMinnie.comRelated Reading: Beware of bias when it comes to residency candidates ISMRM: Charting a course of diversity and inclusion Radiologist salaries are in top 10 of medicine Men greatly outnumber women in academic nuclear medicine How to fix the 'boys' club' in interventional radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2019 Category: Radiology Source Type: news

ANSTO workers exposed to radiation
Three employees from the Australian Nuclear Science and Technology Organization...Read more on AuntMinnie.comRelated Reading: ANSTO licensed to fully supply Mo-99 ANSTO nets funds for nuclear medicine project ANSTO offers virtual reality tours of OPAL reactor Australian reactor to resume Mo-99 shipments this week Australian agency orders review of Mo-99 procedures (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 3, 2019 Category: Radiology Source Type: news

United Imaging makes SNMMI debut in Anaheim
United Imaging Healthcare exhibited at its first Society of Nuclear Medicine...Read more on AuntMinnie.comRelated Reading: United Imaging installs 1st uMI 550 PET/CT in U.S. United Imaging gets FDA nod for PET/MRI scanner United Imaging partners with ITM United Imaging gets FDA nod for total-body PET/CT unit United Imaging breaks into U.S. imaging market (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2019 Category: Radiology Source Type: news

Philips highlights ambient room for FDG uptake
At this week's Society of Nuclear Medicine and Molecular Imaging meeting, Philips...Read more on AuntMinnie.comRelated Reading: Philips integrates AI into latest Epiq CVx upgrade Philips wins long-term contract from Univ. of Vermont Philips gets new FDA OK for MRI treatment planning Philips releases IntraSight interventional app platform Philips' Lumify lands Army airworthiness certification (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2019 Category: Radiology Source Type: news

Siemens adds AI to molecular imaging line at SNMMI
At this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual...Read more on AuntMinnie.comRelated Reading: Siemens, ASRT share Radcademy program FDA clears Siemens' mobile x-ray system Siemens to debut cardio edition of go.TOP CT at ACC Siemens and MRI Interventions sign MRI deal Siemens VP Darrow dies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2019 Category: Radiology Source Type: news

SNMMI announces leadership slate for 2019-2020
ANAHEIM, CA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI)...Read more on AuntMinnie.comRelated Reading: Video from SNMMI 2019: Alan Packard on molybdenum supply Video from SNMMI 2019: Outreach needed to tell discipline's story SNMMI: PET ligand can diagnose brain disorder before autopsy SNMMI: Technetium radiotracer tracks rheumatoid arthritis SNMMI announces new officers for 2018-2019 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2019 Category: Radiology Source Type: news

New combination therapy established as safe and effective for prostate cancer
(Society of Nuclear Medicine and Molecular Imaging) A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

Ultrasmall nanoclusters and carbon quantum dots show promise for acute kidney injury
(Society of Nuclear Medicine and Molecular Imaging) Acute kidney injury (AKI) often complicates the treatment outcomes of hospitalized patients, resulting in dangerous levels of toxic chemicals accumulating in the blood and causing numerous deaths annually. Currently, only supportive treatment is available for AKI, but two related research studies presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging offer hope for effective treatment and prevention. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

Radionuclide therapy effective in high-grade neuroendocrine neoplasms
(Society of Nuclear Medicine and Molecular Imaging) Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 66th Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2019 Category: Cancer & Oncology Source Type: news

Molecular imaging suggests smokers may have impaired neuroimmune function
(Society of Nuclear Medicine and Molecular Imaging) Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 25, 2019 Category: International Medicine & Public Health Source Type: news

SNMMI Image of the Year: Novel radiotracer detects 28 cancer types
(Society of Nuclear Medicine and Molecular Imaging) The results of a study demonstrate that positron emission tomography/computed tomography (PET/CT) with a fibroblast-activation protein inhibitor (FAPI) -- which targets the overexpressed proteins present in cancer -- resulted in images with exceptionally clear tumor delineation and high image contrast, as demonstrated in the 68Ga-FAPI-PET/CT image that has been selected as the 2019 SNMMI Image of the Year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2019 Category: Cancer & Oncology Source Type: news

Video from SNMMI 2019: Outreach needed to tell discipline's story
ANAHEIM, CA - More outreach is needed to explain the value of nuclear medicine...Read more on AuntMinnie.comRelated Reading: SNMMI: PET ligand can diagnose brain disorder before autopsy SNMMI: PET ligand can diagnose brain disorder before autopsy SNMMI: Technetium radiotracer tracks rheumatoid arthritis SNMMI: FDG-PET/MRI improves pain diagnosis, management Video from SNMMI 2019: Dr. Barry Siegel on PET reimbursement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 24, 2019 Category: Radiology Source Type: news

Wearable Technology to Personalize Lu-177-DOTATATE Therapy for NETs
Researchers at the University of Washington in Seattle, Washington, are developing a user-friendly (worn at home) vest with technology that collects data to tailor personalized therapy for patients with metastatic, somatostatin-receptor-2 positive neuroendocrine tumors (NETs). The study was presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: eHealth News EU)
Source: eHealth News EU - June 24, 2019 Category: Information Technology Tags: Featured Development Research and Development Source Type: news

Wearable technology to personalize Lu-177-DOTATATE therapy for NETs
(Society of Nuclear Medicine and Molecular Imaging) Researchers at the University of Washington in Seattle, Washington, are developing a user-friendly (worn at home) vest with technology that collects data to tailor personalized therapy for patients with metastatic, somatostatin-receptor-2 positive neuroendocrine tumors (NETs). The study was presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2019 Category: Cancer & Oncology Source Type: news

Interim scan during prostate cancer therapy helps guide treatment
(Society of Nuclear Medicine and Molecular Imaging) New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging of patients with metastatic castration-resistant prostate cancer after two cycles of lutetium-177 (177Lu)-PSMA radioligand therapy has shown a significant predictive value for patient survival. The research was presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 24, 2019 Category: Cancer & Oncology Source Type: news